Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
This study is ongoing, but not recruiting participants.
Sponsor:
Bayside Health
Collaborator:
Merck
Information provided by (Responsible Party):
Bayside Health
ClinicalTrials.gov Identifier:
NCT01365065
First received: June 1, 2011
Last updated: December 3, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2013 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |